{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:22:34Z","timestamp":1792149754288,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1378\/chest.13-0922","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T11:14:59Z","timestamp":1377256499000},"page":"1564-1570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["\u03b2-Trace Protein and Prognosis in Patients With Atrial Fibrillation Receiving Anticoagulation Treatment"],"prefix":"10.1016","volume":"144","author":[{"given":"Juan Antonio","family":"V\u00edlchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Manzano-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herm\u00f3genes","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Avil\u00e9s-Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mart\u00ednez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Vald\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1378\/chest.13-0922_bib1","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1378\/chest.13-0922_bib2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ahj.2010.03.027","article-title":"Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC)","volume":"159","author":"Soliman","year":"2010","journal-title":"Am Heart J"},{"issue":"5","key":"10.1378\/chest.13-0922_bib3","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"issue":"10","key":"10.1378\/chest.13-0922_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/qjmed\/hcm076","article-title":"Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review","volume":"100","author":"Hughes","year":"2007","journal-title":"QJM"},{"issue":"2","key":"10.1378\/chest.13-0922_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.1993.tb02145.x","article-title":"Purification and chemical characterization of beta-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase","volume":"61","author":"Hoffmann","year":"1993","journal-title":"J Neurochem"},{"issue":"23","key":"10.1378\/chest.13-0922_bib6","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1016\/S0021-9258(17)38889-0","article-title":"Purification and characterization of rat brain prostaglandin D synthetase","volume":"260","author":"Urade","year":"1985","journal-title":"J Biol Chem"},{"issue":"26","key":"10.1378\/chest.13-0922_bib7","doi-asserted-by":"crossref","first-page":"14689","DOI":"10.1073\/pnas.94.26.14689","article-title":"Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients","volume":"94","author":"Eguchi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1378\/chest.13-0922_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/clinchem\/45.4.567","article-title":"Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range","volume":"45","author":"Priem","year":"1999","journal-title":"Clin Chem"},{"issue":"5","key":"10.1378\/chest.13-0922_bib9","first-page":"1316","article-title":"Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function","volume":"15","author":"Verhave","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1378\/chest.13-0922_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1373\/clinchem.2009.138826","article-title":"Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease","volume":"56","author":"Spanaus","year":"2010","journal-title":"Clin Chem"},{"issue":"3","key":"10.1378\/chest.13-0922_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbrc.2005.07.130","article-title":"Sequential induction of prostaglandin E and D synthases in inflammation","volume":"335","author":"Schuligoi","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1378\/chest.13-0922_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.RES.86.9.967","article-title":"Fluid shear stress induces lipocalin-type prostaglandin D(2) synthase expression in vascular endothelial cells","volume":"86","author":"Taba","year":"2000","journal-title":"Circ Res"},{"issue":"2","key":"10.1378\/chest.13-0922_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2008.03.010","article-title":"Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease","volume":"201","author":"Inoue","year":"2008","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1378\/chest.13-0922_bib14","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1291\/hypres.31.1931","article-title":"Association of serum lipocalin-type prostaglandin D synthase levels with subclinical atherosclerosis in untreated asymptomatic subjects","volume":"31","author":"Miwa","year":"2008","journal-title":"Hypertens Res"},{"issue":"7","key":"10.1378\/chest.13-0922_bib15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2010.08.644","article-title":"\u03b2-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure","volume":"57","author":"Manzano-Fern\u00e1ndez","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1378\/chest.13-0922_bib16","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.amjcard.2012.06.027","article-title":"Usefulness of \u03b2-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes","volume":"110","author":"Manzano-Fern\u00e1ndez","year":"2012","journal-title":"Am J Cardiol"},{"issue":"13","key":"10.1378\/chest.13-0922_bib17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","article-title":"Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy","volume":"125","author":"Hijazi","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"10.1378\/chest.13-0922_bib18","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.STR.0000236840.00467.84","article-title":"Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation","volume":"37","author":"Lip","year":"2006","journal-title":"Stroke"},{"issue":"4","key":"10.1378\/chest.13-0922_bib19","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1161\/01.STR.0000260090.90508.3e","article-title":"High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis","volume":"38","author":"Lip","year":"2007","journal-title":"Stroke"},{"issue":"25","key":"10.1378\/chest.13-0922_bib20","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2010.12.033","article-title":"Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients","volume":"57","author":"Rold\u00e1n","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1378\/chest.13-0922_bib21","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1378\/chest.13-0922_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.13-0922_bib23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"6","key":"10.1378\/chest.13-0922_bib24","first-page":"997","article-title":"Bleeding risk assessment and management in atrial fibrillation patients. Executive summary of a position document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis","volume":"106","author":"Lip","year":"2011","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1378\/chest.13-0922_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1378\/chest.13-0922_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1378\/chest.13-0922_bib27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/clinchem\/39.6.1345","article-title":"ROC plots display test accuracy, but are still limited by the study design","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem"},{"issue":"2","key":"10.1378\/chest.13-0922_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"issue":"4","key":"10.1378\/chest.13-0922_bib29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem"},{"issue":"4","key":"10.1378\/chest.13-0922_bib30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1253\/circj.CJ-10-0902","article-title":"Lipocalin-type prostaglandin D synthase is associated with coronary vasospasm and vasomotor reactivity in response to acetylcholine","volume":"75","author":"Matsumoto","year":"2011","journal-title":"Circ J"},{"issue":"5","key":"10.1378\/chest.13-0922_bib31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2215\/CJN.08870812","article-title":"\u03b2-Trace protein: from GFR marker to cardiovascular risk predictor","volume":"8","author":"Orenes-Pi\u00f3ero","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1378\/chest.13-0922_bib32","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archinte.167.4.382","article-title":"Subclinical atherosclerosis and risk of atrial fibrillation: the rotterdam study","volume":"167","author":"Heeringa","year":"2007","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1378\/chest.13-0922_bib33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.ajkd.2011.11.042","article-title":"Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population","volume":"59","author":"Astor","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"20","key":"10.1378\/chest.13-0922_bib34","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.jacc.2013.02.035","article-title":"Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project","volume":"61","author":"Banerjee","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1378\/chest.13-0922_bib35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1160\/TH13-01-0054","article-title":"Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?","volume":"109","author":"Rold\u00e1n","year":"2013","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1378\/chest.13-0922_bib36","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2012.04812.x","article-title":"High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation","volume":"10","author":"Rold\u00e1n","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1378\/chest.13-0922_bib37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCEP.111.967000","article-title":"Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation","volume":"5","author":"Gallego","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"10.1378\/chest.13-0922_bib38","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1253\/circj.CJ-13-0465","article-title":"Stroke prevention with oral anticoagulation therapy in patients with atrial fibrillation\u2014focus on the elderly","volume":"77","author":"Lip","year":"2013","journal-title":"Circ J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213607321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213607321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:38:03Z","timestamp":1757918283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369213607321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0012369213607321"],"URL":"https:\/\/doi.org\/10.1378\/chest.13-0922","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Trace Protein and Prognosis in Patients With Atrial Fibrillation Receiving Anticoagulation Treatment","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.13-0922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}